The Valley Desk

NCT03561259 · Interventional trial

A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects

Overall registry status Unknown

Phase 2

Conditions Neoplasms, Neuroblastoma, Neuroectodermal Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov